Publication | Open Access
Significant Inhibition of Corneal Scarring In Vivo with Tissue-Selective, Targeted AAV5 Decorin Gene Therapy
89
Citations
33
References
2011
Year
Tissue-targeted AAV5-mediated decorin gene therapy is effective and safe for treating corneal fibrosis in vivo.
| Year | Citations | |
|---|---|---|
Page 1
Page 1